Published in J Thromb Haemost on March 06, 2009
Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury. Thromb Haemost (2014) 0.88
Antithrombin is protective against myocardial ischemia and reperfusion injury. J Thromb Haemost (2013) 0.87
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clin Exp Metastasis (2010) 0.79
Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin. Thromb Haemost (2014) 0.76
The cytoprotective protein C pathway. Blood (2006) 5.75
Serpin structure, mechanism, and function. Chem Rev (2002) 5.39
Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem (2005) 3.54
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med (2007) 3.35
Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem (2001) 3.31
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med (2006) 2.07
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A (2007) 1.87
Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry (1984) 1.70
Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science (1999) 1.67
Specificity of coagulation factor signaling. J Thromb Haemost (2003) 1.59
Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost (2008) 1.35
The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol (1997) 1.27
Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J Biol Chem (1998) 1.18
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood (2000) 1.15
Engineering plasminogen activator inhibitor 1 mutants with increased functional stability. Biochemistry (1994) 1.15
Retracted Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood (2002) 1.08
Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood (2001) 1.05
Helix D elongation and allosteric activation of antithrombin. J Biol Chem (2001) 1.05
Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis (2002) 1.04
Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. Blood (2002) 0.98
A comparison of three heparin-binding serine proteinase inhibitors. J Biol Chem (1992) 0.96
Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin. Biochim Biophys Acta (2001) 0.95
The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Blood (2005) 0.94
Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding. Biochemistry (2002) 0.89
Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells. Cancer Res (2006) 0.88
Antithrombin: molecular basis of deficiency. Thromb Haemost (1997) 0.87
Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma. Thromb Res (2006) 0.81
Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells. J Thromb Haemost (2008) 1.88
Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost (2012) 1.71
Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart. J Thromb Haemost (2012) 1.63
The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem (1996) 1.56
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry (1995) 1.47
Electrostatic dependence of the thrombin-thrombomodulin interaction. J Mol Biol (2000) 1.20
Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling. J Thromb Haemost (2011) 1.18
Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. J Biol Chem (1994) 1.09
The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C. J Biol Chem (1997) 1.04
Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem (1996) 1.01
Thrombin upregulates the angiopoietin-Tie2 Axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies. J Thromb Haemost (2010) 0.98
A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem (1998) 0.94
Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity. Biochemistry (1997) 0.94
Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin. Thromb Haemost (2009) 0.91
Identification and characterization of the sodium-binding site of activated protein C. J Biol Chem (1999) 0.90
Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation. J Biol Chem (1994) 0.88
Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. J Thromb Haemost (2009) 0.87
Antithrombin is protective against myocardial ischemia and reperfusion injury. J Thromb Haemost (2013) 0.87
Identification of a binding site for quaternary amines in factor Xa. Biochemistry (2000) 0.83
Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population. Thromb Haemost (2013) 0.80
Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol (2000) 0.80
The role of autolysis loop in determining the specificity of coagulation proteases. Braz J Med Biol Res (2007) 0.79
Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells. J Thromb Haemost (2015) 0.78
Humanization of an antibody against human protein C and calcium-dependence involving framework residues. Protein Eng (1998) 0.77